MedTrace Logo

Probiotics for Irritable Bowel Syndrome

NCT00355810 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2016-07-19

No results posted yet for this study

Summary

This randomised, double blind, cross-over study compares the effect (symptoms, fecal bacterial growth, gas production) of three weeks' treatment with lactobacillus plantarum MF 1298 with placebo in patients with irritable bowel syndrome. The results are related to dietary habits, food intolerance and food allergy.

Conditions

  • Functional Gastrointestinal Disorders
  • Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

placebo followed by Lactobacillus plantarum MF 1298

placebo during 3 weeks, washout period 4 weeks, Lactobacillus plantarum MF1298 during 3 weeks

DIETARY_SUPPLEMENT

Lactobacillus plantarum MF1298 followed by placebo

Lactobacillus plantarum MF1298 during 3 weeks, washout period 4 weeks, placebo during 3 weeks

Sponsors & Collaborators

  • Norwegian Food Research

    collaborator UNKNOWN

  • Gilde

    collaborator OTHER

  • Norwegian Foundation for Health and Rehabilitation

    collaborator OTHER

  • Sykehuset Innlandet HF

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Per G Farup, PhD · Norwegian University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2006-04-30
Completion
2006-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00355810 on ClinicalTrials.gov